Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 3Supratentorial Neoplasms 2Oligodendroglioma 2Medulloblastoma 2Kidney Neoplasms 2Central Nervous System Neoplasms 2Astrocytoma 2Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Postoperative Complications 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive 1Neoplasms, Germ Cell and Embryonal 1Nasopharyngeal Carcinoma 1Intracranial Hypertension 1Hemorrhage 1Gliosarcoma 1Glioma 1Glioblastoma 1Familial ependymoma 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

Cyclophosphamide 9Temozolomide 7Radiotherapy 6Magnetic Resonance Spectroscopy 5Filgrastim 5Cisplatin 5Carboplatin 5antineoplaston AS 2-1 4antineoplaston A10 4Etoposide 4sargramostim 3Vincristine 3Thiotepa 3Melphalan 3Automobiles 3fludarabine 2aldesleukin 2Thalidomide 2Surveys and Questionnaires 2Granulocyte Colony-Stimulating Factor 2Gemcitabine 2Gadolinium DTPA 2Eflornithine 2Donepezil 2Carmustine 2Biopsy 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2trifluridine tipiracil drug combination 1trametinib 1thymoglobulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neuroectodermal Tumors, Primitive × Mannitol × Clear all
NCT00983398 2021-10-26

Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors

OHSU Knight Cancer Institute

Phase 1/2 Unknown
17 enrolled
CNS

Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡